Cargando…

Sitafloxacin for Third-Line Helicobacter pylori Eradication: A Systematic Review

Background and Aim: Sitafloxacin-based therapy is a potent candidate for third-line Helicobacter pylori eradication treatment. In this systematic review, we summarise current reports with sitafloxacin-based therapy as a third-line treatment. Methods: Clinical studies were systematically searched usi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishizawa, Toshihiro, Munkjargal, Munkhbayar, Ebinuma, Hirotoshi, Toyoshima, Osamu, Suzuki, Hidekazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234224/ https://www.ncbi.nlm.nih.gov/pubmed/34202993 http://dx.doi.org/10.3390/jcm10122722

Ejemplares similares

Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication
por: Nishizawa, Toshihiro, et al.
Publicado: (2009)

Increasing trend of Helicobacter pylori-uninfected gastric cancer without gastric atrophy
por: Nishizawa, Toshihiro, et al.
Publicado: (2022)

Clinical features of cardiac nodularity-like appearance induced by Helicobacter pylori infection
por: Nishizawa, Toshihiro, et al.
Publicado: (2020)

Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate against Sitafloxacin-Resistant Helicobacter pylori
por: Saito, Yoshimasa, et al.
Publicado: (2019)

Helicobacter pylori eradication improved the Kyoto classification score on endoscopy
por: Toyoshima, Osamu, et al.
Publicado: (2020)

Nodularity-like appearance in the cardia: novel endoscopic findings for Helicobacter pylori infection
por: Toyoshima, Osamu, et al.
Publicado: (2020)

Long-Term Outcomes of Endoscopic Submucosal Dissection for Colorectal Epithelial Neoplasms: A Systematic Review
por: Nishizawa, Toshihiro, et al.
Publicado: (2022)

Effects of patient age and choice of antisecretory agent on success of eradication therapy for Helicobacter pylori infection
por: Nishizawa, Toshihiro, et al.
Publicado: (2017)

Characteristics of gastric cancer detected within 1 year after successful eradication of Helicobacter pylori
por: Nishizawa, Toshihiro, et al.
Publicado: (2016)

Effects of Encircled Abdominal Compression Device in Colonoscopy: A Meta-Analysis
por: Nishizawa, Toshihiro, et al.
Publicado: (2019)

Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2012)

Additional Mosapride to Proton Pump Inhibitor for Gastroesophageal Reflux Disease: A Meta-Analysis
por: Nishizawa, Toshihiro, et al.
Publicado: (2020)

TXI (Texture and Color Enhancement Imaging) for Serrated Colorectal Lesions
por: Nishizawa, Toshihiro, et al.
Publicado: (2021)

Current Status of the Third-Line Helicobacter pylori Eradication
por: Choi, Jae Ho, et al.
Publicado: (2018)

Kyoto classification in patients who developed multiple gastric carcinomas after Helicobacter pylori eradication
por: Sakitani, Kosuke, et al.
Publicado: (2020)

Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing
por: Nishizawa, Toshihiro, et al.
Publicado: (2014)

Endoscopic Kyoto classification of Helicobacter pylori infection and gastric cancer risk diagnosis
por: Toyoshima, Osamu, et al.
Publicado: (2020)

Early detection of gastric cancer after Helicobacter pylori eradication due to endoscopic surveillance
por: Sakitani, Kosuke, et al.
Publicado: (2018)

Helicobacter pylori infection in subjects negative for high titer serum antibody
por: Toyoshima, Osamu, et al.
Publicado: (2018)

Improvement of reflux symptom related quality of life after Helicobacter pylori eradication therapy
por: Hirata, Kenro, et al.
Publicado: (2013)

Gastric Carcinogenesis and Underlying Molecular Mechanisms: Helicobacter pylori and Novel Targeted Therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2015)

Helicobacter pylori rescue treatment with vonoprazan, metronidazole, and sitafloxacin in the presence of penicillin allergy
por: Sue, Soichiro, et al.
Publicado: (2021)

Gastric cancer incidence based on endoscopic Kyoto classification of gastritis
por: Toyoshima, Osamu, et al.
Publicado: (2023)

A combination of serum anti-Helicobacter pylori antibody titer and Kyoto classification score could provide a more accurate diagnosis of H pylori
por: Nishizawa, Toshihiro, et al.
Publicado: (2019)

Efficacy and safety of low‐dose rifabutin‐based 7‐day triple therapy as a third‐ or later‐line Helicobacter pylori eradication regimen
por: Inokuchi, Kazumi, et al.
Publicado: (2022)

The simplified Kyoto classification score is consistent with the ABC method of classification as a grading system for endoscopic gastritis
por: Nishizawa, Toshihiro, et al.
Publicado: (2021)

Risk Factors for Prolonged Hospital Stay after Endoscopy
por: Nishizawa, Toshihiro, et al.
Publicado: (2021)

Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication
por: Huang, Hsiang Tso, et al.
Publicado: (2018)

Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease
por: Lim, Joo Hyun, et al.
Publicado: (2017)

Therapeutic Potential of Sitafloxacin as a New Drug Candidate for Helicobacter Eradication in Korea: An In Vitro Culture-Based Study
por: Choi, Youn I, et al.
Publicado: (2021)

Serum anti-Helicobacter pylori antibody titer and its association with gastric nodularity, atrophy, and age: A cross-sectional study
por: Toyoshima, Osamu, et al.
Publicado: (2018)

Small-caliber endoscopes are more fragile than conventional endoscopes
por: Nishizawa, Toshihiro, et al.
Publicado: (2019)

H. pylori-Eradication Therapy Increases RUNX3 Expression in the Glandular Epithelial Cells in Enlarged-Fold Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2010)

Current status of first- and second-line Helicobacter pylori eradication therapy in the metropolitan area: a multicenter study with a large number of patients
por: Mori, Hideki, et al.
Publicado: (2019)

Endoscopic gastric atrophy is strongly associated with gastric cancer development after Helicobacter pylori eradication
por: Toyoshima, Osamu, et al.
Publicado: (2016)

Helicobacter pylori: Eradication or Preservation
por: Sachs, George, et al.
Publicado: (2012)

Hemorrhagic Colitis Induced by Second-line Helicobacter pylori Eradication
por: Hamada, Yasuhiko, et al.
Publicado: (2019)

Adverse events associated with bidirectional endoscopy with midazolam and pethidine
por: Nishizawa, Toshihiro, et al.
Publicado: (2020)

Effectiveness of including probiotics to Helicobacter pylori eradication therapies
por: Mukai, Rieko, et al.
Publicado: (2020)

Efficacy of Sequential Therapy as the First-Line Treatment in the Eradication of Helicobacter pylori
por: Tamene, Yonas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rv9avsiq89prrr1i4hkj8pq4e2